Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Topics in Microbiology and Immunology|August 2, 2011
Ricin vaccine developmentJoan E Smallshaw, Ellen S VitettaVaccine|January 16, 2010
A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicityJoan E Smallshaw, Ellen S VitettaJournal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3Joan E Smallshaw, Elaine Coleman, Camelia Spiridon, et al.Vaccine|September 19, 2007
RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosolJoan E Smallshaw, James A Richardson, Ellen S VitettaClinical and Vaccine Immunology : CVI|August 24, 2012
Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccineEllen S Vitetta, Joan E Smallshaw, John SchindlerJournal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell linesElaine J Coleman, Kimberly J Brooks, Joan E Smallshaw, et al.Toxins|November 10, 2011
Passive and active vaccination strategies to prevent ricin poisoningSeth H Pincus, Joan E Smallshaw, Kejing Song, et al.Vaccine|June 18, 2005
Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricinJoan E Smallshaw, James A Richardson, Seth Pincus, et al.Acta Crystallographica. Section D, Biological Crystallography|September 10, 2011
Structure of RiVax: a recombinant ricin vaccinePatricia M Legler, Robert N Brey, Joan E Smallshaw, et al.Vaccine|June 22, 2010
Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxicationPraveena S Marconescu, Joan E Smallshaw, Laurentiu M Pop, et al.Pageof 2